Trim 25% CL at $91-$91.50 into resistance, stop $95.50, retain 75% core through Q3
Quality defensive franchise, wrong price, deteriorating tape, real forward cost test in Q3. Trim 25% (not 50%) in tranches at $91.00-$91.50 (not into phantom $92-93 bounce), with $95.50 stop on trimmed portion (not indefensible $99.33), retain 75% core for dividend + structural support at $86-88, define re-engagement on either 200 SMA convergence with positive MACD divergence OR Q3 print validation. Price target $87.50.
| Position | Action |
|---|---|
| Current positioning with 22.1x forward P/E at top of 18-21x historical band, broken 50 SMA, negative MACD with expanding histogram, Q2 EPS -5.5% YoY miss | Trim 25% of CL holdings in tranches at $91.00-$91.50 |
| Q3 earnings late October 2026 as forcing event | Retain 75% core position to capture structural bid at $86-88 zone and dividend carry (~0.5% per quarter) |
| Confirmed Q3 beat: accelerating organic volume + sustained margin expansion + maintained buyback pace | Upgrade to Hold, ultimately Overweight if margin durability confirmed through Q4 |
| Q3 miss with margin compression | Trigger another trim tranche toward Underweight median sizing |
Colgate-Palmolive is a defensive compounder at a structural volume-growth inflection, with margin expansion, raised guidance, and a compressed technical setup that historically resolves upward for a stock with an intact long-term trend.
| Indicator | Value | Signal |
|---|---|---|
| 10 EMA | 91.35 | bearish |
| 50 SMA | 91.70 | bearish |
| 200 SMA | 86.63 | bullish |
| RSI | 46.94 | neutral |
| MACD | −0.14 | bearish |
| MACD Signal | −0.02 | bearish |
| MACD Histogram | −0.12 | bearish |
| Bollinger Middle | 91.78 | neutral |
| Bollinger Upper | 94.06 | neutral |
| Bollinger Lower | 89.50 | neutral |
| ATR | 1.87 | neutral |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
↩ rebuts: “Bear: 'Staples cannot grow margins'”
EV: +3.3% to +7.7% (near-term target $94; Q3 confirmation target $98 vs ~$91 current price) · concedes: North America weakness is real but well-flagged, well-discounted, and not accelerating; TTM operating margins slipped from 22% to 21%, though this reflects Q3 2025 charge working through trailing window; Volume-weighted participants are currently underwater at $91.48 vs $90.75 close; TTM P/E of 35.7x appears elevated (though attributed to one-time charge); Venezuela 100-year oil lease could be a near-term cost headwind before becoming a medium-term tailwind
CL is a crowded defensive trade priced for perfection at a multi-year high, with structurally weakening core franchise, margin compression, technical distribution signals, and a valuation at the top of its historical range that leaves asymmetric downside risk.
EV: -$3.37 to $3.10 (approximately 1:1 in most likely scenarios) · concedes: 63 consecutive years of dividend increases is impressive; Dividend is fully covered by FCF today; Volume improvement is real, just not transformational; 200 SMA is still rising (long-term trend intact); CL is a quality franchise with strong brand portfolio
→ vs conservative: The trend that worked has already played out; 0.33 beta name with 1-2% organic growth doesn't compound fast enough at 22.1x forward P/E; dividend yield now below Treasuries; not protecting a thesis, defending a multiple
→ vs neutral: Waiting for Bollinger break confirmation at $89.50 means already giving back $1.25/share; multi-year compression zones at multi-year valuation highs historically resolve down more often than up; waiting for the move you're trying to avoid is indecision dressed as patience
| VWMA | 91.48 | bearish |
Support: 89.5 · 88.16 · 86.63 | Resistance: 91.78 · 94.06
CL is trading at $90.75, sitting below both the 10 EMA (91.35) and 50 SMA (91.70) while remaining firmly above the 200 SMA (86.63). The stock is in a compression zone between the Bollinger Lower Band ($89.50) and Middle Band ($91.78), with RSI neutral at 46.94 and MACD histogram slightly negative at −0.12, indicating a consolidation phase rather than a directional trend. Key support lies at $89.50 (Bollinger Lower) and $86.63 (200 SMA), while resistance sits at $91.78 (Bollinger Middle) and $94.06 (Bollinger Upper). ATR of 1.87 suggests below-average volatility. Recommended stance is HOLD for existing positions and WAIT for new entries until a breakout above $91.78–$92.00 or breakdown below $89.50 on above-average volume.
Market Cap
$72.34 B
P/E Ratio (TTM)
35.73x
Forward P/E
22.09x
PEG Ratio
1.76
Price/Book
306.59x
EPS (TTM)
$2.54
Forward EPS
$4.11
Dividend Yield
2.33%
52-Week High
$99.33
52-Week Low
$74.55
50-Day Avg
$91.91
200-Day Avg
$87.39
Beta
0.327
Gross Margin
~60.4%
Operating Margin
20.97%
Net Profit Margin
9.68%
EBITDA (TTM)
$4.98 B
Return on Equity (ROE)
267.4%
Return on Assets (ROA)
15.84%
Free Cash Flow (TTM)
$3.46 B
Total Debt
$7.86B
Net Debt
$6.49B
Stockholders' Equity
$236M
Treasury Stock
$28.93B
Current Ratio
1.026
Goodwill
$3.10B
Q2 2026 Revenue
$5,361M
Q2 2026 Gross Profit
$3,296M
Q2 2026 Operating Income
$1,016M
Q2 2026 Net Income
$693M
Q2 2026 Diluted EPS
$0.86
Q2 2026 Operating Cash Flow
$995M
Q2 2026 CapEx
-$128M
Q2 2026 Free Cash Flow
$867M
Q2 2026 Dividends Paid
-$462M
Q2 2026 Buybacks
-$291M
Strengths
Concerns
Colgate-Palmolive presents as a high-quality defensive holding with stable cash flows, a strong dividend, and improving balance sheet dynamics. The TTM valuation looks stretched only because of a one-time Q3 2025 non-cash charge; on forward earnings the stock trades at a more reasonable ~22x. With a 0.33 beta, expanding margins, and consistent revenue growth, CL is fundamentally a "hold and collect the dividend" name rather than a momentum play. The recent shift toward debt reduction over buybacks suggests management may be preparing the balance sheet for a strategic move or simply de-risking for macro reasons.
Macro: Fed pricing remains aggressively hawkish at 89% probability of zero cuts in 2026 (+3.3pp week-over-week), while soft-landing consensus holds at just 8% recession probability by year-end. Geopolitically, U.S. is launching Iran sanctions with Hormuz remaining closed and oil prices spiking—adding near-term cost pressure. Venezuela 100-year oil lease under negotiation would add long-dated supply (medium-term oil bearish). U.S. futures under pressure ahead of Nvidia earnings amid stretched AI trade. CL positioned as defensive beneficiary of hawkish-Fed/soft-landing combo but faces USD headwind from firm dollar.